Pharmacy Technician's Letter Canada | Monthly CE & Tracking

March 2026 Issue

Be Familiar With Oral Semaglutide for Heart Protection

Oral semaglutide (Rybelsus) will now be used to lower cardiovascular risk in some adults with high-risk type 2 diabetes...

Resources

Algorithm: Stepwise Treatment of Type 2 Diabetes
Chart: Diabetes Medications: Cardiovascular and Kidney Impact

Put Meds for Uterine Fibroids in Perspective

Up to 80% of females develop uterine fibroids over their lifetime...

Know How Meds for Fibromyalgia Stack Up

You’re in a prime position to help patients with fibromyalgia who have symptoms such as pain, mood, and sleep issues...

Stay Alert for Confusing Abbreviations

Abbreviations may save time now...

GO TO FULL ISSUE

CE & Training

FEATURED SELF-STUDY CE: Identification and Management of Drug Allergies

CE-IN-THE-LETTER: Canadian Pharmacy Technician's Letter March 2026

LIVE CE: Pharmacy Essential Updates March 2026

PODCAST CE: Clinical Capsules - Hypothyroidism Meds: Answers to Common Questions

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Inhalation Medications for Asthma (Canada)

What is Pharmacy Technician's Letter Canada?

Pharmacy Technician's Letter Canada is your one-stop shop for CE and monthly updates about new meds, OTCs, patient safety, professional skills, and more. Learn more >

Group Purchases & Pricing

Pharmacy Technician’s Letter Canada is eligible for bulk discounts. Ensure technicians meet license renewal requirements. Easily manage staff access. Bundle with other products for significant savings. Request information